[Leu5]-Enkephalin TFA

CAS No. ——

[Leu5]-Enkephalin TFA( Leu-enkephalin | Leucine enkephalin | Leucyl-enkephalin )

Catalog No. M21007 CAS No. ——

[Leu5]-Enkephalin is the most potent δ-receptor ago.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 52 Get Quote
25MG 108 Get Quote
50MG 162 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [Leu5]-Enkephalin TFA
  • Note
    Research use only, not for human use.
  • Brief Description
    [Leu5]-Enkephalin is the most potent δ-receptor ago.
  • Description
    [Leu5]-Enkephalin is the most potent δ-receptor ago.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Leu-enkephalin | Leucine enkephalin | Leucyl-enkephalin
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    δ-opioid receptor|Human Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    669.64
  • Molecular Formula
    C30H38F3N5O9
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O.O=C(O)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Robert J Cassell Krishna K Sharma Hongyu Suet al.The Meta-Position of Phe 4 in Leu-Enkephalin Regulates Potency Selectivity Functional Activity and Signaling Bias at the Delta and Mu Opioid Receptors[J].Molecules 24 (24) 2019 Dec 1
molnova catalog
related products
  • Orphanin FQ (1-11)

    Peptide fragment containing amino acids 1-11 of Nociceptin. Potent agonist of the ORL1/KOR-3 receptor (Ki = 55 nM); displays no affinity for opioid receptors, including μ, δ, κ1 and κ3 receptors (Ki >1000 nM). Displays analgesic properties in CD-1 mice.

  • Eluxadoline

    A potent, selective, orally bioavailable μ-opioid receptor agonist and a δ-opioid receptor antagonist for the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D).

  • Alvimopan dihydrate

    A selective peripherally acting μ-opioid antagonist with IC50 of 1.7 nM for the treatment of postoperative ileus; prevents gastrointestinal effects of intravenous morphine without affecting analgesia; orally active.